US2006039951A1PendingUtilityA1

Inorganic shaped bodies and methods for their production and use

Assignee: VITA SPECIAL PURPOSE CORPPriority: Jan 26, 1999Filed: May 24, 2005Published: Feb 23, 2006
Est. expiryJan 26, 2019(expired)· nominal 20-yr term from priority
A61L 27/12C04B 38/009A61F 2/32A61P 19/00A61B 17/80Y10T428/2982A61F 2/2875C04B 32/00C04B 28/34C04B 2111/00793C04B 38/0025A61C 8/0012C04B 2111/0081A61F 2/28A61B 17/72A61F 2250/0058C04B 2111/00836Y10S977/906A61F 2002/30535A61B 17/866
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Shaped, preferably porous, inorganic bodies are provided which are prepared from a reactive blend. In accordance with one preferred embodiment, the solution is absorbed into a porous sacrificial substrate such as a cellulose sponge. The solution-saturated substrate is heated and an oxidation-reduction reaction occurs thereby forming an inorganic solid. A shaped, inorganic body is formed in situ. Optional, but preferred additional thermal treatment of the shaped, inorganic body removes the organic substrate, leaving an inorganic body that faithfully mimics the porosity, shape, and other physical characteristics of the organic substrate. Inorganic substrates may also be used to good effect. Large varieties of shaped bodies can be prepared in accordance with other embodiments of the invention and such shapes find wide use in surgery, laboratory and industrial processes and otherwise. The invention also provides chemically and morphologically uniform powders, including those having uniformly small sizes.

Claims

exact text as granted — not AI-modified
1 . A shaped body for restoring or repairing bone in an animal comprising a material having a total pore volume of at least about 30%, said material being a combination of calcium phosphate and hydroxyapatite, the calcium phosphate having macro-, meso- and microporosity.  
     
     
         2 . The shaped body of  claim 1  wherein the calcium phosphate has a crystallite size less than 1 μm.  
     
     
         3 . The shaped body of  claim 1  wherein the calcium phosphate is tricalcium phosphate.  
     
     
         4 . The shaped body of  claim 1  wherein the calcium phosphate is beta-tricalcium phosphate.  
     
     
         5 . The shaped body of  claim 1  wherein the total pore volume is at least about 50%.  
     
     
         6 . The shaped body of  claim 1  wherein the total pore volume of at least about 80%.  
     
     
         7 . A shaped body for restoring or repairing bone in an animal comprising a material having a total pore volume of at least about 30%, said material being a combination of calcium phosphate and a stable polymeric compound, the calcium phosphate having macro-, meso-, and microporosity.  
     
     
         8 . The shaped body of  claim 7  wherein the stable polymeric compound is lactate.  
     
     
         9 . The shaped body of  claim 7  wherein the stable polymeric compound is gelatin.  
     
     
         10 . The shaped body of  claim 7  wherein the stable polymeric compound is wax.  
     
     
         11 . The shaped body of  claim 7  wherein the stable polymeric compound is polylactate.  
     
     
         12 . A shaped body for restoring or repairing bone in an animal comprising a material having a total pore volume of at least about 80%, said material being a combination of 
 calcium phosphate having macro-, meso- and microporosity and a crystallite size less than 1 μm; and    a medicament.    
     
     
         13 . The shaped body of  claim 12  wherein the medicament is a growth hormone, antibiotic, or a cell signaling material.  
     
     
         14 . An inorganic anisotropic membrane comprising a calcium phosphate material having substantially uniform macro-, meso-, microporosity together with a pore volume of at least about 30%.  
     
     
         15 . The inorganic anisotropic membrane of  claim 14  wherein said pore volume is at least about 50%.  
     
     
         16 . The inorganic anisotropic membrane of  claim 14  wherein said pore volume is at least about 70%.  
     
     
         17 . The inorganic anisotropic membrane of  claim 14  wherein said pore volume is at least about 80%.  
     
     
         18 . The inorganic anisotropic membrane of  claim 14  wherein said pore volume is at least about 90%.  
     
     
         19 . The inorganic anisotropic membrane of  claim 14  wherein said membrane is in the shape of a cylinder, core, truncated cone, sleeve, or concavo-convex surface.  
     
     
         20 . The inorganic anisotropic membrane of  claim 14  wherein the shaped body is in the shape of a mammalian bone.  
     
     
         21 . The inorganic anisotropic membrane of  claim 14  wherein the shaped body is in the shape of a human bone.  
     
     
         22 . The inorganic anisotropic membrane of  claim 14  wherein the shaped body is in the shape of a vertebra.  
     
     
         23 . The inorganic anisotropic membrane of  claim 14  wherein the calcium phosphate comprises tri-calcium phosphate.  
     
     
         24 . The inorganic anisotropic membrane of  claim 14  wherein the calcium phosphate comprises beta-tri-calcium phosphate.  
     
     
         25 . The inorganic anisotropic membrane of  claim 14  wherein said pore volume is at least about 90% and the calcium phosphate comprises beta-tri-calcium phosphate.  
     
     
         26 . A catalytically impregnated reactor comprising a ferrous-containing material and calcium phosphate material having substantially uniform macro-, meso-, microporosity together with a pore volume of at least about 30%.  
     
     
         27 . The reactor of  claim 26  further comprising at least one housing containing said ferrous-containing materials and said calcium phosphate.  
     
     
         28 . The reactor of  claim 26  wherein said calcium phosphate material has a pore volume of at least about 80%.  
     
     
         29 . The reactor of  claim 26  wherein said calcium phosphate has a crystallite size less than 1 μm.  
     
     
         30 . The reactor of  claim 26  wherein said calcium phosphate comprises tricalcium phosphate.  
     
     
         31 . The reactor of  claim 26  wherein said calcium phosphate comprises beta tricalcium phosphate.

Join the waitlist — get patent alerts

Track US2006039951A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.